Allie Nawrat

You can get in touch with Allie on Alexandra.Nawrat@verdict.co.uk

All articles by Allie Nawrat

  1. RedHill’s opaganib authorised for compassionate use in Italy

    Gastrointestinal disease-focused US-Israeli biopharma company RedHill has received authorisation from the Italian National Institute for Infectious Diseases and Central Italian…
    Read More…

    6 Apr
  2. GSK and Vir collaborate on Covid-19 drug and vaccine R&D

    GlaxoSmithKline (GSK) and infectious disease specialists Vir Biotechnology have signed an agreement to collaborate on researching and developing drugs and…
    Read More…

    6 Apr
  3. Coronavirus company news summary

    6 April 2020  Researchers from the Biomedicine Discovery Institute (BDI) at Monash University,  Australia, have found that an anti-parasitic drug…
    Read More…

    6 Apr
  4. Clinova studies rehydration product’s ability to speed up recovery from Covid-19

    UK-based consumer health company Clinova initiates a UK study into the effectiveness of its oral rehydration solution (ORS) in Covid-19…
    Read More…

    6 Apr
  5. Novartis and Incyte to trial Jakavi for Covid-19

    Novartis, in alliance with Incyte, has announced plans to evaluate Jakavi (ruxolitinib) in a Phase III clinical trial to treat…
    Read More…

    3 Apr
  6. ImmunityBio and Microsoft create 3D model to support Covid-19 research

    Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s…
    Read More…

    2 Apr
  7. Gates Foundation’s Covid-19 accelerator makes first investments

    The Bill & Melinda Gates Foundation, Wellcome and Mastercard’s Covid-19 Therapeutics Accelerator, which was launched in mid-March with $125m, has…
    Read More…

    2 Apr
  8. ImmunityBio and Microsoft create 3D model to support Covid-19 research

    Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create a 3D model of Covid-19’s…
    Read More…

    2 Apr
  9. Exscientia forms UK-US partnership to screen possible Covid-19 drugs

    AI drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond Light…
    Read More…

    1 Apr
  10. Exscientia forms UK-US partnership to screen possible Covid-19 drugs

    Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond…
    Read More…

    1 Apr
Close
Close
Close

Go Top